- 全部删除
- 您的购物车当前为空
NP3-562 is a powerful, orally administered tricyclic NLRP3 inhibitor, demonstrating an IC₅₀ of 214 nM. At a dosage of 30 mg/kg given orally (p.o.), NP3-562 effectively suppresses IL-1β release in a mouse model of acute peritonitis [1].
NP3-562 is a powerful, orally administered tricyclic NLRP3 inhibitor, demonstrating an IC₅₀ of 214 nM. At a dosage of 30 mg/kg given orally (p.o.), NP3-562 effectively suppresses IL-1β release in a mouse model of acute peritonitis [1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
NP3-562 相关产品
产品描述 | NP3-562 is a powerful, orally administered tricyclic NLRP3 inhibitor, demonstrating an IC₅₀ of 214 nM. At a dosage of 30 mg/kg given orally (p.o.), NP3-562 effectively suppresses IL-1β release in a mouse model of acute peritonitis [1]. |
靶点活性 | NLRP3:214 nM |
分子量 | 437.94 |
分子式 | C19H24ClN5O3S |
CAS No. | 2409825-32-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容